291 related articles for article (PubMed ID: 28504893)
1. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.
Knez D; Sova M; Košak U; Gobec S
Future Med Chem; 2017 May; 9(8):811-832. PubMed ID: 28504893
[TBL] [Abstract][Full Text] [Related]
2. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F
Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
Sun Y; Chen J; Chen X; Huang L; Li X
Bioorg Med Chem; 2013 Dec; 21(23):7406-17. PubMed ID: 24128814
[TBL] [Abstract][Full Text] [Related]
4. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.
Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S
Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569
[TBL] [Abstract][Full Text] [Related]
5. Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives.
Wang Y; Sun Y; Guo Y; Wang Z; Huang L; Li X
J Enzyme Inhib Med Chem; 2016; 31(3):389-97. PubMed ID: 25798687
[TBL] [Abstract][Full Text] [Related]
6. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease.
Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M
Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents.
Yang J; Zhang P; Hu Y; Liu T; Sun J; Wang X
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):651-656. PubMed ID: 30746966
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease.
Huang ST; Luo JC; Zhong GH; Teng LP; Yang CY; Tang CL; Jing L; Zhou ZB; Liu J; Jiang N
Drug Des Devel Ther; 2024; 18():133-159. PubMed ID: 38283137
[TBL] [Abstract][Full Text] [Related]
10. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
[TBL] [Abstract][Full Text] [Related]
11. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.
Farina R; Pisani L; Catto M; Nicolotti O; Gadaleta D; Denora N; Soto-Otero R; Mendez-Alvarez E; Passos CS; Muncipinto G; Altomare CD; Nurisso A; Carrupt PA; Carotti A
J Med Chem; 2015 Jul; 58(14):5561-78. PubMed ID: 26107513
[TBL] [Abstract][Full Text] [Related]
13. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y
Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.
Weinreb O; Amit T; Bar-Am O; Youdim MB
Br J Pharmacol; 2016 Jul; 173(13):2080-94. PubMed ID: 26332830
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
16. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
[TBL] [Abstract][Full Text] [Related]
17. Rational design of new multitarget histamine H
Łażewska D; Bajda M; Kaleta M; Zaręba P; Doroz-Płonka A; Siwek A; Alachkar A; Mogilski S; Saad A; Kuder K; Olejarz-Maciej A; Godyń J; Stary D; Sudoł S; Więcek M; Latacz G; Walczak M; Handzlik J; Sadek B; Malawska B; Kieć-Kononowicz K
Eur J Med Chem; 2020 Dec; 207():112743. PubMed ID: 32882609
[TBL] [Abstract][Full Text] [Related]
18. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.
Pachón-Angona I; Refouvelet B; Andrýs R; Martin H; Luzet V; Iriepa I; Moraleda I; Diez-Iriepa D; Oset-Gasque MJ; Marco-Contelles J; Musilek K; Ismaili L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):479-489. PubMed ID: 30712420
[TBL] [Abstract][Full Text] [Related]
19. Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.
Bautista-Aguilera ÓM; Budni J; Mina F; Medeiros EB; Deuther-Conrad W; Entrena JM; Moraleda I; Iriepa I; López-Muñoz F; Marco-Contelles J
J Med Chem; 2018 Aug; 61(15):6937-6943. PubMed ID: 29969030
[TBL] [Abstract][Full Text] [Related]
20. Dual Monoamine Oxidase and Cholinesterase Inhibitors with Different Heterocyclic Scaffolds.
Gulcan HO; Orhan IE
Curr Top Med Chem; 2021; 21(30):2752-2765. PubMed ID: 34477521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
